Task: Answer the multiple choice question.
Question: Which drug exhibits a -21.567% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a) O=S(=O)(c1cccc(-c2nc3n(n2)Cc2ccccc2-3)c1)N1CCCCC1
b) CSc1ncccc1C(=O)NC1CCN(Cc2ccccc2)CC1
c) CC(=O)NC1C(=O)N=C(SCC(=O)NCc2ccccc2)NC1=O
d) CCN(CC)CCN(Cc1cc2cc3c(cc2[nH]c1=O)OCO3)C(=S)NC
Answer: c. CC(=O)NC1C(=O)N=C(SCC(=O)NCc2ccccc2)NC1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)NC1C(=O)N=C(SCC(=O)NCc2ccccc2)NC1=O
CC(=O)NC1C(=O)N=C(SCC(=O)NCc2ccccc2)NC1=O
2-[(5-acetamido-4,6-dioxo-1H-pyrimidin-2-yl)sulfanyl]-N-benzylacetamide